The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta S,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz R,
Witzenbichler B,
Kastrati A,
Han Y,
Steg PG,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study
Asano T,
Kogame N,
Onuma Y,
Modolo R,
Chichareon P,
Lefèvre T,
Legutko J,
Digne F,
Morel M,
Serruys P,
Gil R
October 23, 2020 | 10.4244/EIJ-D-19-00361
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study
Vassilev D,
Dosev L,
Collet C,
Karamfiloff K,
Stoikova J,
Pancheva R,
Shumkova M,
Zlatancheva G,
Naunov V,
Rigatelli G,
Kassab G,
Gil R,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00189
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Gil R,
Bil J,
Grundeken M.J,
Kern A,
Iñigo Garcia L,
Vassilev D,
Pawłowski T,
Formuszewicz R,
Dobrzycki S,
Wykrzykowska JJ,
Serruys P
December 9, 2016 | 10.4244/EIJY15M11_11
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Gil R,
Bil J,
Grundeken M.J,
Iñigo Garcia L,
Vassilev D,
Kern A,
Pawłowski T,
Wykrzykowska JJ,
Serruys P
November 20, 2016 | 10.4244/EIJY15M10_05
Dedicated stents for distal left main stenting
May 19, 2015 | 10.4244/EIJV11SVA29
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population
Gil R,
Vassilev D,
Michalek A,
Kern A,
Formuszewicz R,
Dobrzycki S,
Wójcik J,
Lesiak M,
Kardaszewicz P,
Lekston A
July 27, 2012 | 10.4244/EIJV8I3A50
Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model
September 30, 2011 | 10.4244/EIJV7I5A98
Latest news
AHEAD OF PRINT
Ticagrelor monotherapy in PCI patients with prior CABG: the TWILIGHT-CABG study
FREE ARTICLE - Gennaro Sardella et al
August 18, 2022
AHEAD OF PRINT
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system
FREE ARTICLE - Emmanuel Teiger et al
August 16, 2022
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022